Vericel (VCEL) Change in Inventory (2014 - 2026)
Vericel's (VCEL) quarterly Change in Inventory came in at $964000.0 in Q1 2026, up 461.05% year-on-year from $171821.1 in Q1 2025, and up 115.18% quarter-over-quarter from $448000.0 in Q4 2025.
Vericel (VCEL) Change in Inventory (2014 - 2026) Analysis & Trends
Vericel has disclosed Change in Inventory across 13 years of filings, most recently posting $964000.0 for Q1 2026.
- Change in Inventory for Q1 2026 came in at $964000.0, up 461.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (down 30.66% YoY), and the FY2025 annual result was $1.2 million, down 71.3% from the prior year.
- Change in Inventory came in at $964000.0 for Q1 2026 at Vericel, up from $448000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $1.6 million in Q4 2024 to a low of -$1.5 million in Q2 2023.
- The 5-year median for Change in Inventory is $470000.0 (2024), against an average of $363882.4.
- Peak annual rise in Change in Inventory reached 700.0% in 2022, while the deepest fall reached 330.75% in 2022.
- Vericel's Change in Inventory stood at -$743000.0 in 2022, then surged by 162.72% to $466000.0 in 2023, then surged by 247.0% to $1.6 million in 2024, then slumped by 72.29% to $448000.0 in 2025, then jumped by 115.18% to $964000.0 in 2026.
- The last three Change in Inventory figures came in at $964000.0 (Q1 2026), $448000.0 (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 964,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 964,000.00 |
| Mar 31, 2026 | 964,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -275,000.00 |
| Mar 31, 2025 | -267,000.00 |
| Mar 31, 2025 | -267,000.00 |
| Dec 31, 2024 | 1.62 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 869,000.00 |
| Sep 30, 2024 | 869,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 470,000.00 |
| Mar 31, 2024 | 470,000.00 |
| Dec 31, 2023 | 466,000.00 |
| Dec 31, 2023 | 466,000.00 |